The Searle Company Limited (PSX:SEARL)

Market Cap	61.84B
Revenue (ttm)	30.67B
Net Income (ttm)	-903.39M
Shares Out	588.22M
EPS (ttm)	-1.54
PE Ratio	43.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,001,105
Average Volume	8,876,127
Open	109.95
Previous Close	109.47
Day's Range	104.01 - 110.20
52-Week Range	52.75 - 119.75
Beta	0.53
RSI	46.25
Earnings Date	Feb 26, 2026

About The Searle Company

The Searle Company Limited, together with its subsidiaries, manufactures and sells pharmaceutical and other consumer products in Pakistan, Sri Lanka, Myanmar, Cambodia, Vietnam, Iraq, Oman, Afghanistan, Tajikistan, Laos, Kenya, and internationally. The company offers pharmaceutical products, such as analgesics and muscle relaxants, anti-allergy and anti-tussive, anti-anemic, anti-chelating, anti-infective, anti-neoplastic, anti-thrombotic, cardiovascular, endocrinology and metabolism, gastrointestinal, gynecology, urology and sex hormones, hepa...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1965
• Employees: 3,799
• Stock Exchange: Pakistan Stock Exchange
• Ticker Symbol: SEARL

Financial Performance

In 2025, The Searle Company's revenue was 28.60 billion, a decrease of -2.72% compared to the previous year's 29.40 billion. Losses were -1.40 billion, -41.15% less than in 2024.